Dow Jones Newswires reports, “The FDA said Brookstone Pharmaceuticals LLC has voluntarily begun recalling its Concentrated Acetaminophen Drops,” to keep patients from “accidentally overdosing on the product.” Currently, “acetaminophen…is under intense scrutiny by the FDA because high-doses of the medicine are the leading cause of liver damage.” The company called the recall “a cautionary measure” aimed at minimizing “any confusion and potential risk to patients from dosing errors.”
From the American Association for Justice news release.
